14 August 2011

What’s in the Price? A Market, Sector, and Stock Guide ::Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

What’s in the Price? A Market, Sector, and Stock Guide


Key Debate: A growth scare is gaining
momentum. So, what exactly is in the price?
Still a stock-pickers’ market
Our biggest takeaway is that valuation dispersion
remains elevated and, combined with the high level of
return correlation across stocks, supports our case for
stock picking in what looks like a range-bound market in
the near term. The market is implying an equity risk
premium of 6.7%, a level exceeded only 8% of the time
over the past five years. The market is quite pessimistic
on growth, but may not be pricing in a complete collapse
in growth. The market is bullish on consumer stocks
while appearing less enthusiastic on cyclicals and
financials. Industrials stand out in terms of how little is in
the price.


What’s in the Price? A Market, Sector, and Stock Guide
• Key Debate: A growth scare is gaining momentum. So what exactly
is in the price?
• Still a stock-pickers’ market: Our biggest takeaway is that
valuation dispersion remains elevated and, combined with the high
level of return correlation across stocks, supports our case for stock
picking in what looks like a range-bound market in the near term.
• The market is implying an equity risk premium of 6.7%: Our
residual income model indicates that implied equity risk premium is
at 6.7%. At the current long bond yield, this implies a long-term
return of 15.1%. This level of equity risk premium has been
exceeded only 8% of the time over the past five years and is a level
from which investors have made good returns even on a one-year
time frame. The last time we were at similar levels was in Feb-10.
• The market is quite pessimistic about growth: Put another way,
the market is assigning 54% of the MSCI Index value to future
growth. This is lower than the trailing five-year average and puts
equities in a positive light for long-term investors. We were last at
this level in Jun-09. Bottom line is that the market is quite pessimistic
on growth, but may not be pricing in a complete collapse in growth.
• The market is bullish on consumer stocks while appearing less
enthusiastic about cyclicals and financials: Consumer staples are
pricing in excess of 25% growth for the five years beyond F2013. In
contrast, the number is 8% for industrials and 9% for financials.
Industrials appear to stand out in terms of how little is in the price. It
is also the sector with the widest gap to the what’s in the price using
consensus numbers, implying a more constructive MS analyst view.
• Key Sector and Stock Conclusions: Our work at the stock level
shows that the market is pricing in negative EPS growth for the next
five years for 23 stocks or 19% of the stocks we analyzed


• Our Methodology: We use our growth discounter model to compute the implied
EPS growth. This model has a two-stage process. We first compute the EPS growth
that the market is discounting (g(mkt)) using the Gordon’s Growth Model. We then
compute the EPS growth that the sector or stock is discounting by using the
following identity:
PE (Sector or Stock)/PE for mkt = ((1+g(sector/stock))^5)/(1 + g(mkt)))^5)
We use the F2013 PE for both the sector/stock and the market given that we have
explicit forecasts the next two years for both MS and the consensus. Thus, the
model gives us the growth embedded in the stock or sector for the next five years.
Of course there are assumptions in this model. It assumes that the sector or stock
will grow at the market rate for year 6 onwards. It also assumes that the sector and
stock multiples converge to the market multiple beyond five years. This penalizes
growth sectors but is largely balanced out by the assumption that all sectors have a
beta of one (which flatters growth sectors).




UBS:: ICICI Bank - NIM beat but fees muted

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
ICICI Bank
N IM beat but fees muted
􀂄 Event: Q1 results in line with UBS-e
Q1FY12 net profit at Rs13.3 (+30% y/y) came in line while better margins
supported NII growth of 21%y/. Other highlights: 1) loans grew 20%y/y, 2%q/q, 2)
Average CASA improved 1% point q/q to 40%, 3) fee income grew 12% y/y, 4)
asset quality remained stable with net NPA at 94bp and provision coverage
marginally inched up to 77%, 5) MFI slippage of Rs2bn out of total slippage of
Rs7.5bn, 6) it has converted shares pledged as security to acquire 30% stake in a
borrower company called GTL Ltd.
􀂄 Impact: Maintain estimates
We expect growth of 18% CAGR over FY12-13 with 25 bps improvement in
NIMs over next 12 months due to better international margins and reduction in
securitization losses. We bring down Fee growth for FY12/13 to 18% from 20%
earlier. We are building in LLP at 80bps/90bps in FY12/13.
􀂄 Action: Buy Rating, PT 1350
We expect earnings to grow at 21% CAGR and consol earnings at 26% CAGR
over FY12-13. We continue to like ICICI Bank for its improving metrics and
relatively better asset quality among peers. The stock trades at 15x FY12
consolidated earnings and 1.8x book (adj for subs).
􀂄 Valuation: Preferred pick in the sector
We value the company on sum of the parts method. We roll over to mid FY13 and
at our price target of Rs1350, the standalone business trades at 2.3x FY13 book and
16.7x FY13 standalone earnings. We value its subsidiaries at Rs320 per share.


􀁑 ICICI Bank
ICICI Bank is the largest private sector bank and the second largest bank in
India. It has an asset base of Rs3.66trn. The bank had a network of 1,520
branches at the end of October 2009.
􀁑 Statement of Risk
We believe a sustained economic slowdown could impact the banking and
finance sector on several fronts: lead to a slowdown in credit, increase NPL risk,
impact fee income, and exert pressure on NIM.

UBS :: Jagran Prakashan Q 1 FY12—a mixed quarter

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Jagran Prakashan
Q 1 FY12—a mixed quarter
􀂄 Event: Q1 revenues below and net profit ahead of UBS-e
Q1 FY12 standalone revenues grew 13% YoY to Rs3,046m, 4% below UBS-e of
Rs3,165m due to lower advertising revenues (+8% YoY) as volumes came under
pressure. Jagran expects ad revenues to grow 14-15% in FY12. EBITDA declined
9% YoY to Rs820m (UBS-e Rs823m). The EBITDA margin came in at 26.9%
(UBS-e 26.0%). Jagran maintained FY12 EBITDA margin guidance at 28-29%.
Newsprint price rose to cRs31,000/kg (+9% QoQ) due to higher prices and change
in mix. Net profit declined 11% YoY to Rs497m (UBS-e Rs468m).
􀂄 Impact: maintain earnings estimates
Jagran achieved 22-23% of our FY12 EBITDA and net profit estimates in Q1. We
maintain our FY12 overall revenue growth forecast at 13%, ad revenue growth at
15%, and EBITDA margin at 28.5%. We believe ad revenue growth is likely to be
strong in H2, partly due to election advertising in Uttar Pradesh (UP).
􀂄 Action: maintain positive view on Jagran
Jagran benefits from rapidly growing advertising spending in tier 2 and 3 cities due
to strong economic growth and increasing consumption compared with metros.
Jagran has a strong leadership position in print media in UP—one of the largest
Hindi print media markets with an estimated market size of Rs8bn.
􀂄 Valuation: maintain Buy with price target of Rs145
We derive our price target from our FY13 EPS estimate of Rs8.71 and 16.5x
FY13E PE in line with its historical trading average.


Maruti Suzuki- Jul'11 Sales decline -26% yoy led by weak demand environment and production realignment:: JPMorgan,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Maruti Suzuki India Ltd Neutral
MRTI.BO, MSIL IN
Jul'11 Sales decline -26% yoy led by weak demand
environment and production realignment


 Sales growth moderated sharply to 75,300 units (-25% yoy) : Unit sales
continue to be impacted by the inflationary environment, which is leading to
consumers pushing back on their car purchases. Sales were also impacted by
the phasing out of the old Swift amd the shifting of production of the Dzire
to the Gurgaon plant– which impacted sales by c.17,000 units.
 All round decline in sales: The Mini segment (M800, A-Star, Alto,
Wagon R) declined -16% yoy on weak demand, the Compact segment
(Swift, Estilo, Ritz) declined -56% yoy due to the phasing out of the old
Swift, Super Compact segment (Dzire) declined -64% yoy due to shifting
the production of this model to the Gurgaon plant and the Vans segment
(Omni, Eeco) declined -2% yoy.
 Export sales at 8,796 units declined -18% yoy as offtake from Europe
remains muted. While the OEM has broad based its markets (inlcuding
Middle East, etc.) - it has only been able to partially offset the slowdown in
Maruti's largest export market.
 JPY continues to appreciate: The JPY has appreciated by c.9% vs the
USD and INR since Mar’11. Given that imports comprise c.25% of Maruti’s
sales, the strengthening of the Japanese Yen will likely impact margins over
2H.
 Global OEMs announce capacity expansion: Ford Motors last week
announced it will spend Rs40Bn to set up its second plant in Gujarat with an
initial annual capacity of 240,000 units (which will come on-stream in 2014).
The OEM plans to launch 8 new products by 2015 and is also expanding its
capacity in Chennai. Toyota will spend Rs16.5Bn to enhance its
manufacturing capacity in India by 100k units by 2013 – to 310,000 units.
 Our View: Over the month, the stock (+5% mom) has outperformed the
broader market (-2% mom) as the 1Q financial results surprised on the
upside. We re-iterate that industry growth will likely moderate in FY12E
and are Neutral on this stock.

Tata Motors- Jul'11 India sales decline on falling passenger car sales, LCV's hold up- JPMorgan,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Tata Motors Overweight
TAMO.BO, TTMT IN
Jul'11 India sales decline on falling passenger car
sales, LCV's hold up


 July India sales decline -6% yoy led by passenger cars, while CV's hold
up: Tata Motors’ India sales (including exports) came in at 63,761 vehicles
(-6% yoy). While domestic commercial vehicle sales held up at +14% yoy,
domestic passenger vehicles sales (-39% yoy) declined sharply. Exports
were up +36% yoy.
 Heavy Commercial Vehicle sales growth is sedate (+4% yoy): The
domestic M&HCV sales growth was muted at 15,836 units - the M/HCV
industry has been witnessing anemic growth given slowing IIP and a
demanding base effect. Tata Motors has gained market share during the
quarter, given its broad based product / geographical reach.
 LCV sales growth +22% yoy sustains – LCV sales continued their strong
uptrend at 24,962 units. Despite a challenging environment, sales of ultra
light tonne trucks continues to be driven by demand for last mile distribution
- especially in semi urban India.
 Passenger car sales (-39% yoy) decline sharply: The domestic passenger
vehicle sales reported offtake of 18,924 units (17,192 Tata + 1,102 Fiat),
down -39% yoy. Nano sales at 3,260 units were down -64% yoy. Indica
sales at 5,860 units declined -32% yoy while Indigo sales were down by
-30% to 4,877 units. SUVs (Sumo/Safari/Aria) sales came at 3,195 units
(down 2% yoy). Passenger car sales have been declining given rising
competitive intensity as well as moderating industry growth.
 Exports are up 36% yoy: The OEM reported export sales of 5,771 units
(+36% yoy) in July. The cumulative export sales for the fiscal are at 20,567
nos. (+25% yoy).
 Outlook: On the domestic segment, we believe that growth rates will be
impacted given the impact of the recent interest rate hike. Global sales will
likely be driven by the Range Rover ‘Evoque’ (the model has received
18,000 pre bookings already) as well as healthy sales in China.

Pharma Pill August 2011 -Monthly Update ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Pharma Pill August 2011 -Monthly Update 
ICICI Securities Limited
Q 1 F Y 1 2 -   G r o w t h   i n   t a c t ,  m a r g i n s   u n d e r   p r e s s u r e
In July and early August most of the companies from the pharma
universe declared Q1FY12 numbers. Although lower domestic growth
was off-set by strong growth in the US and emerging markets, we could
see margin pressure across the universe. Lower realizations in the US
and higher raw materials and staff cost was the reason cited by most of
the companies. In terms of overall performance, Glenmark, Strides, Ipca
and Divi’s were the standout performers. Sun’s numbers got boost on
account of improved Taro profitability. Lupin and Aurobindo had to cope
up with lower US realizations and higher operating cost despite decent
sales growth. Cadila had a `rest’ quarter after a hectic FY11. Cipla,
despite muted top-line growth was able to maintain margins on account
of changed product mix. In case of Dr Reddy’s good show in the US and
Russia was marred by tepid India growth. Ranbaxy had to cope up with
lower Aricept (Anti-Alzheimer’s) realization and margin pressure in base
business. Higher licensing fee boosted the top-line of Torrent whilst
lower licensing fee dented Biocon numbers. Opto continued to register
robust growth, thanks to acquisitions in the past. In the domestic market
only Glenmark, Lupin, and Sun (Adjusted) among others were able to
clock above average growth.
On the R&D front, Glenmark completed phase 1 trial evaluating GRC
15300 as a treatment for pain and might sought candidate for outlicensing for further development. On the regulatory front, Cadila
received USFDA approval for its Baddi facility. Ironically the same
company received warning letter for violation of CGMP practices for its
Ahmedabad facility. In a unique global tie-up US based Gilead has tied
up with four Indian players to develop Anti-Aids drugs. On the M&A front
Dr Reddy’s acquired JB Chemical’s Russian prescription business while
Cadila acquired Animal healthcare company in Germany.
S e c t o r   v i e w
The healthcare index continued its  out-performance vis-à-vis broader
markets in July. As mentioned in the July issue, this was mainly on
account of relative resilience to global shocks, in line Q1FY12 numbers
amidst margin pressure and better visibility of future performance. The
margin pressure was mainly on account of pricing pressure in acute
therapies in both the US and India. The field force expansion in India also
added some pressure. Going ahead,  we expect improvement on this
front on account of chronic therapy  focus, improved contribution from
the new field force and rural penetration. Good traction from the US,
Japan and other developed markets supported by product approvals, a
growing presence in Pharmerging markets and a strong foothold in India
are some aspects that will continue to weigh on the relative out
performance vis-à-vis broader markets.

Power Finance Corp – Key highlights of 1QFY12 earnings :RBS

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


■ In 1QFY12, PFC reported 5% yoy growth in net profit to Rs6.9bn.
■ However, adjusted for one-offs and exchange gains/loss, the adjusted net profit increased
14% yoy to Rs7.2bn.
■ Net interest income grew 15.4% yoy to Rs9.9bn in 1QFY12.
■ The reported spreads fell 37bp yoy to 2.28% in 1QFY12 (2.5% in FY11).
■ The company has recognised an exchange loss of Rs765m in 1QFY12 vs a Rs672m loss in
1QFY11 (Rs250m gain in 4QFY11).
■ Loan assets grew 22% yoy (up 4.5% qoq) to Rs1,041bn as of June 2011.
■ Loan sanctions grew 17% yoy to Rs169bn.
■ Disbursements fell 24% yoy to Rs62bn (down 48% qoq)
■ The book value per share as of June 2011 was Rs138 and the reported earnings per share
for the quarter is Rs5.6.
At the current price, the stock trades at 7.8x FY12F earnings and 1.1x FY12F book value.

ICICI Bank -1Q12 results — no surprises:: Credit Suisse,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


● ICICI’s 1Q profits (+30% YoY) were as expected (4% lower vs
street). Both loan growth at 21% YoY (18-19% guidance for full
year) and NIMs at 2.6% (-10 bp QoQ) were in line with estimates.
Disappointment during 1Q was modest (+6%) growth in fees (core
fee +12% YoY) and as these have started to lag loan growth,
ROAs moderating during the quarter from 4Q levels.
● Consol profits (+53% YoY) were 25% higher than standalone, as
slowdown in new business (-41% YoY) is aiding a sharp rise in life
insurance a/c profits. However, with NBAP down 68% YoY, we
expect little embedded value growth.
● Asset quality was stable but provisions up 18% QoQ to meet new
RBI norms. Rapid increase in bank’s exposure to infra and real
estate sectors given headwinds faced by many of these highly
leveraged corporates may weigh on stock performance.
● We believe, with little upside to ROA as credit costs have likely
bottomed and valuations at 2.1x FY12 core book (core ROE
14%), stock offers limited upside and maintain NEUTRAL.
No surprises in the operating performance
Corp loans remained a key driver, contributing 170% of incremental
domestic lending in 1Q (54% of incremental share over past year).
Retail growth remained weak (down 1% QoQ; +8% YoY) and is
currently at 37% of loans. Deposit growth was in line with loan growth
(2% QoQ).
NIMs held up well but fees growth dropped
While reported CASA share dropped 320 bp QoQ to 42% (savings
deposits growth at 18% YoY) mainly due to outflow of seasonal
current a/c deposits, average CASA was stable at 40%. NIMs
therefore fell only 10 bp QoQ to 2.6% as expected (domestic NIMs at
3.0%, int’l NIMs at 0.9%). The bank expects FY12 NIMs at around
2.6% levels. The disappointment during the quarter was the modest
(+6% YoY) growth in fees (core fee were 12% YoY) driven by weak
distribution and slowdown in corporate activities. Cost-income was up
216 bp QoQ to 45% with revision in base salaries.

Consol profits boosted by life insurance accounting profits
Consol 1Q profits (+53% YoY) were 25% higher than standalone
profits, as slowdown in new business (-41% YoY) is aiding a sharp
rise in life insurance a/c profits (Rs3.4 bn profit in 1Q12 vs. Rs1.2 bn
loss in 1Q11). However, with new business premiums falling and
margins under pressure, NBAP was down 68% YoY and we expect
little embedded value growth at the life insurance business.

Credit costs may have bottomed, likely headwinds on corp
loans
Gross NPLs were largely unchanged but provisions up 18% QoQ as
expected (credit costs 0.8%) due to Rs1.5 bn additional provisions to
meet new RBI norms. However, post rapid increase in bank’s exposure
to sectors such as real estate and infrastructure and headwinds being
faced by many such highly leveraged corporates, we expect newsflow,
for instance its yesterday’s acquisition of the 30% pledged stock of
telecom infra co. GTL, to weigh on the bank’s stock performance as it
highlights its relatively large exposure to these sectors.

Credit Suisse:: Reliance Power-Lenders refuse to disburse loans for Krishnapatnam UMPP

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


● As per a news report in the Economic Times, lenders for Reliance
Power’s 3.96 GW Krishnapatnam UMPP have refused to disburse
loans for the project due to concerns about project feasibility given
likely increase in coal cost because of changes in Indonesian
mining regulations.
● Reliance Power expected to source coal for Krishnapatnam
UMPP from its Indonesian coal mines at US$35/t, but with the
new regulations, coal cost is likely to rise to US$65/t, implying
losses of Rs2.33/kWh at contracted tariff. Hence, Reliance Power
has requested the Indian government to revise its tariff upwards.
● The Ministry of Power has now requested the Andhra Pradesh
government (primary project beneficiary) to intervene in the matter
and find a solution with Reliance Power. However, the way ahead
for Krishnapatnam UMPP remains unclear.
● As previously highlighted, if tariff negotiations fail, Reliance Power
could opt to surrender the project to minimise losses. This could
imply a loss of Rs4.5 bn (Rs1.6/sh) in terms of capex incurred and
bank guarantees submitted. Besides, this would most likely be
litigated by project beneficiaries. Maintain UNDERPERFORM.
Indonesian mining regulations threaten project economics
Krishnapatnam UMPP is a 3.96 GW imported coal-based project
awarded to Reliance Power through competitive bidding (Case II
bidding) process at a levelised tariff of Rs2.33/kWh. To meet the coal
requirements of this project, Reliance Power acquired three coal
mines in Indonesia. Reliance Power’s bidding was based on the
expectation of procuring coal from Indonesia at about US$35/t at its
project site (landed cost).
However, in Sep 2010, the Indonesian government introduced a new
regulation, Benchmark Price Regulation, requiring all Indonesian coal
producers to export coal at or above a benchmark price (determined
based on certain indices) for each grade of coal. Besides, this
regulation is expected to be implemented with retrospective effect,
requiring even existing coal supply contracts to be modified by Sep
2011. The new regulation implies all tax and royalty payments made
to the Indonesian government shall be based on benchmark prices (or
actual selling price, whichever is higher). This would result in landed
coal cost for Krishnapatnam project to increase to US$65/t (as per
company’s estimate).
Figure 1: Key specifications of the 3.96 GW Krishnapatnam UMPP
Capacity (MW) 3,960 (6x660)
Location Andhra Pradesh
Project cost (Rs bn) 175.0
Debt:Equity 75:25
Debt (Rs bn) 131.3
Equity (Rs bn) 43.8
Bid tariff (Rs/kWh) 2.33 (levelised)
Fuel type Imported coal
Fuel source Indonesian coal mines acquired by Reliance Power
Scheduled COD September 2013 (Unit-1)
Power offtake Andhra Pradesh (1.6GW), Maharashtra (0.8GW), Tamil Nadu
(0.8GW), Karnataka (0.8GW)
Lead arranger IDBI Bank
Joint lead arranger Power Finance Corporation (PFC)
Lending consortium REC, LIC, UCO Bank, Union Bank, Andhra Bank, Corporation
Bank, PNB, IOB, SBBJ, State Bank of Hyderabad, Vijaya
Bank, Punjab and Sind Bank, Yes Bank, Indian Bank
Source: Company data, Credit Suisse estimates
Reliance Power has requested for tariff revision
Reliance Power, through The Association of Power Producers, has
represented to the Indian Government for revising its tariff upwards for
the Krishnapatnam project to absorb the likely increase in fuel costs.
Developers, like Reliance Power, argue that these costs should be
permitted to be passed under the ‘change in law clause’ in their power
supply contracts.
Lenders back away from funding Krishnapatnam UMPP
As per a news report in the Economic Times, given concerns about
project feasibility in view of the likely increase in coal cost because of
the change in Indonesian mining regulations, lenders have now
refused to disburse loans for the project. Recently, media reports also
highlighted that work on the Krishnapatnam project has been stalled
as per the site survey conducted by a team of officials from the CEA,
Ministry of Power and APPGCL. As per the news report, the Ministry
of Power has now requested the Andhra Pradesh government
(primary beneficiary of the project) to intervene in the matter and work
out a solution with Reliance Power.
Way ahead for Krishnapatnam UMPP remains unclear
As highlighted in our note dated 11 July 2011, titled Surprises from
Krishnapatnam UMPP likely, if Reliance Power is disallowed to revise
Krishnapatnam UMPP’s tariff upwards, then it could opt to surrender
the project to minimise its losses. This could result in litigations from
the beneficiaries of the project. Besides, the company could lose
Rs1.5 bn (mostly equity funded) already invested in the project and
Rs3 bn bank guarantee could also be confiscated. We continue to
maintain our UNDERPERFORM rating on the stock.

Nestlé India- Danone to enter baby foods market ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Nestlé India Limited Neutral
NEST.BO, NEST IN
Danone to enter baby foods market


 Danone to move into the India baby foods market. Danone (covered
by JPM analyst Polly Barclay) has signed an agreement with Wockhardt
Group to acquire its nutrition business and thus enter the baby nutrition
and medical nutrition markets in India. Under the agreement, Danone
will acquire Wockhardt’s nutrition business and brands as well as its
related industrial operations (located in Punjab) for ~€250 mn.
Wockhardt’s baby nutrition brands include Dexolac, Farex and
Nusobee, which together account for ~7% share of the India baby food
market, as per Euromonitor. In addition, the nutritional supplement brand
Protinex is likely to give Danone a strong foundation for developing its
medical nutrition business.
 Rationale for Danone’s acquisition. Danone is trying to enhance its
presence (both in terms of product categories and geographical reach) in
India. It started testing Indian waters with the launch of yoghurt (regular
and flavored) in Indian markets about a year back and is in the process of
scaling that up. This acquisition is likely to provide Danone with access
to a wider distribution network (chemists particularly).
 More competition for Nestlé long term? Nestlé India is the market
leader in the baby foods category in India with a share of over 75%.
Baby foods cannot be advertised in India (by regulation), which acts as a
significant entry barrier for a new brand. With the acquisition, Danone
has tried to leverage on Wockhardt’s existing brand franchise to expand
its product reach. Clearly this move will be keenly monitored to see any
incremental impact on Nestlé’s baby food brands over the medium term;
these brands have had a fairly stable market share over the past few
years.
 India baby foods market. The Indian baby foods market is estimated to
be ~Rs17.5bn (as per Euromonitor). Nestlé is the dominant player with
~75% share. In India, per capita consumption of baby foods is quite low
(refer Fig 3) which highlights potential for growth in this category.
Furthermore over 25mn children are born in India each year, making it
one of the fastest growing infant nutrition markets globally.
 Global infant nutrition market. The global infant nutrition market is
consolidated. The three largest players – Nestlé, Danone and Mead
Johnson – account for approximately half the market and the six largest
players – Nestlé, Danone, Mead Johnson, Abbot, Pfizer and Heinz –
account for roughly two-thirds of the market (ref. Fig 2). Asia Pacific is
the largest infant formula milk market by region accounting for 45%
of the global infant formula milk market.

Mahindra & Mahindra -Jul'11 Sales (+33% yoy) driven by automotive segment ::JPMorgan,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Mahindra & Mahindra Overweight
MAHM.BO, MM IN
Jul'11 Sales (+33% yoy) driven by automotive
segment


M&M’s unit sales grew +33% yoy over the month, with growth being
driven by the automotive segment (+43% yoy). The farm equipment
segment sales grew (+15% yoy).
 Automotive segment saw healthy growth of +43% yoy driven by the
ramp up of the Maximmo and the recently launched Genio pick up –
thus, LCV’s grew to 13,472 units (+91%yoy). Passenger UV sales
(+35% yoy) continued to report impressive growth. Low value three
wheeler sales were flat yoy. The management highlighted that current
waiting periods on their products has reduced, given the recent impact of
the interest rate hikes. However, they re-iterated that M&M would grow
ahead of the industry for the year, driven by its refreshed product
portfolio.
 Farm equipment sales grow: Tractor sales at 16,718 units were up
+15% yoy - driven by the prospects of a normal monsoon. While sales
are up 19% YTD, management has re-iterated its FY12E forecast growth
rates which are likely to be in low double digits.
 At our recent conference in New York, management had indicated that
industry growth rates are likely to be in the range of 10-12% for tractors
and 11-13% for UVs in FY12. The OEM is ramping up production of the
‘Yuvraj’ tractor to 20,000 units in the year (from 10,000 in FY11); on
UVs – they expect to launch the new W201 SUV by the end of the year.
 Over the month, the stock price (+6% yoy) outperformed the broader
BSE Sensex (-2% yoy). We re-iterate our OW stance on the stock as we
think the OEM will benefit from a refreshed UV product portfolio as
well as sustained growth in the FES segment

JSW Steel - Preliminary read from the mining ban and impact on JSW ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


JSW Steel Neutral
JSTL.BO, JSTL IN
Preliminary read from the mining ban and impact on
JSW


JSW so far has not made any public comments on the implications of the
SC ban on all mining activities. Stock has corrected 21% in the last 4
trading sessions. While JSTL is now trading below book value (0.85x
FY12E), gauging the earnings impact is very difficult as of now.
 Iron ore implications for JSTL: We would like to highlight that as of
now JSTL has not made any public comments on the implications
from the entire issue. JSW sources most of its iron ore from the Bellary
Hospet region in Karnataka (where the SC has banned mining) via a
combination of captive iron ore, from NMDC (NR) and from local
miners. The ban essentially would impact across the board iron ore
sourcing for the company and depending on the duration of the ban,
could significantly impact production and/or cost of production. Over the
last 1 year, domestic spot prices in Karnataka had fallen very sharply
given the export ban (state owned miner NMDC had to cut prices). JSTL
had commented that iron ore costs were Rs2700/MT ($60/MT) v/s FOB
prices of $150-160/MT. Local prices are adjusted for the 20% export
duty and the high transportation costs. We estimate a 1% increase in
iron ore costs impact consolidated EPS by 1.4%. However, if the
duration of the ban is longer, then sourcing large quantities of iron ore,
either from the Chitradurga area or from Goa, would not be very easy,
and costs would increase driven by a) demand supply mismatch; b)
transport costs increase and c) lower grade iron ore impacting costs. This
would lower steel production from the new expansion.
 Impact on financials: A push up in the cost curve would also push up
steel prices, thus possibly mitigating some of the impact. However given
that JSTL is in the process of commissioning its 3MT BF, fixed costs
like depreciation and interests costs would also rise materially this year
(we estimate 26% y/y increase in FY12E). Net debt/equity stood at 1.1x
FY11 (we include the Acceptances as part of debt).
 Duration of the ban: There is no clarity on the duration of the mining
ban. We estimate that total sponge iron production in Karnataka was
c.0.5MT in FY11. We estimate steel production in Karnataka at near
11MT (c.20% of India's total steel production). Given this
background, we believe a long term ban on iron ore production is
unlikely.
 Stock below book: JSTL has corrected sharply over the last few days,
post the publication of the ‘Lokayukta Report’ (report is in the public
domain). We are not worried on the leverage given the recent stake sale
to JFE. JSTL is now trading below Book Value (0.85x FY12E, last time
was during GFC), however there is likely to be high degree of
uncertainty till the mining ban issue is resolved.

July 2011: A month of negative surprises ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


 MSCI India (US$) lost 2.5% over the month and underperformed
the MSCI Emerging markets index (down 0.7%). Telecom, Consumer
Discretionary and Health Care companies were relative outperformers,
while Industrials, Energy and Materials underperformed.
 RBI surprises again with higher-than-expected rate hike. The Central
bank hiked benchmark Repo and Reverse Repo rate by 50 bps each,
against consensus expectations of 25 bps. RBI also maintained its
hawkish stance and increased the fiscal-year-end inflation forecast from
6.0% to 7.0%. RBI’s key objective remains anchoring still-elevated
inflationary expectations in the economy.
 Disappointing Q1 FY12 earnings reporting’s so-far. A large set of
companies – 45% of JPM’s coverage universe – have reported
disappointing quarterly earnings performance owing to margin
pressures. No clear sectoral trend is apparent, though.
 May IP disappointed. May IP grew at a significantly lower-thanexpected
5.8% oya. The disappointment came from the Capital goods
and Consumer Durables segment.
 FIIs buyers, DII sellers. FIIs were buyers over the month and bought
US$1,807mn into Indian equities. DII were sellers over the month.
Insurance companies sold US$167mn while domestic mutual funds
bought US$122 mn over the month.
 Other key developments over the month:
 INR appreciated by 1.5% vs. the US$ over July
 Headline WPI Inflation for June reported at 9.44%.
 10 year treasury yield increased 15 bps to 8.45% over July


Hindalco Industries- Higher costs impact earnings ::RBS

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��



Hindalco Industries
Higher costs impact earnings
Hindalco reported 1QFY12 EBITDA of Rs8.7bn (+4% yoy and -5% qoq), in-line
with our expectation. Though volumes of both aluminium and copper were mute,
robust LME price and higher Tc/Rc and byproduct realizations drove earnings.
We maintain Buy on attractive valuations with TP of 277.
Largely in-line results
 Aluminium metal production was 140.4kt (flat both yoy and qoq) 2% lower than our estimate.
Alumina production at Renukoot has been impacted due to constrained bauxite availability.
Downstream sales were also impacted by sluggish demand. Copper cathode production was
however only 73.2kt (-4% yoy and -14% qoq), impacted by the bi-annual shutdown at one of
the smelters at Dahej.
 Driven by higher realizations of both copper and aluminium, net revenues were at Rs60.3bn
(+16% yoy and -12% qoq). Employee costs declined 11% qoq to Rs2.5bn. Power and fuel
costs rose sharply to Rs6.3bn (+25% yoy and +8% qoq) as the full impact of the 30% price
hike by Coal India took effect. EBITDA came in at Rs8.7bn (+4% yoy and -5% qoq), 4% lower
than our estimate of Rs9.0bn. While Aluminium EBIT was at Rs5.9bn (+8% yoy and +7% qoq)
due to higher LME, copper EBIT was at Rs1.4bn (+17% yoy and -29% qoq), driven by higher
Tc/Rc and byproduct realizations, despite lower volumes.
 Other income was at Rs1.8bn, up sharply yoy both due to higher corpus of cash due to
Novelis dividend repatriation as well as dividend of Rs0.69bn from Aditya Birla Minerals, the
Australian mining subsidiary. This drove PAT to Rs6.4bn (+21% yoy and -9% qoq) versus our
estimate of Rs5.9bn.
Mt Gordon of ABML operations restart
 At Aditya Birla Minerals Limited, copper in concentrate production declined 24% yoy to 11.8kt
due to an expected sharp decline in grade which fell from 3.05% to 2.20% yoy. Mt Gordon
operations have re-started and production ramp-up is progressing. Copper prices remaining
elevated is a positive for earnings, though increased operating cost and strength of AUD pose
a risk.
Greenfield expansion update
 The 359kt Mahan smelter with 900MW CPP is on schedule to be commissioned by end 2011

Out of the project finance of Rs78bn, Rs34bn has been drawn so far. However, coal remains
a concern with the advisory committe of the MoEF rejecting the forest diversion proposal,
though a Group of Ministers have been constituted to decide on the same. The company has
also applied for tapering linkage.
 The utkal alumina project commissioning has been pushed back with the company now
expecting it at "second half 2012" rather than "2012" earlier. The company continues to guide
Aditya aluminium smelter commissioning for early 2013. Stage 2 forest clearance has been
obtained and financing option is currently being evaluated. The company has noted that
severe inflationary pressure is being witnessed for the greenfield projects despite long lead
equipment having been tied up.
Brownfield expansion update
 The Hirakud smelter expansion from 155kt to 161kt was completed in 4QFY11. This should
positively impact volumes from 2Q onwards. The expansion from 161kt to 213kt along with
100MW CPP will be commissioned in early 2012. The Hirakud FRP project is also on
schedule for completion by end 2011.
Hindalco valuations attractive; Maintain Buy
 Trading at 7.9x/7.1x FY12/13F earnings and 6.5x/6.2x FY12/13F EV/EBITDA, we believe
valuations are attractive. Even ignoring the robust expansion pipeline in aluminium, the
existing businesses are available at a discount, in our view. We have a Buy rating on
Hindalco with TP of Rs277.

DLF - Asset monetization is key ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


DLF’s inability to reduce debt has been the main overhang on its share
price. While FY11 cash flows were masked by various PE buyouts, 1Q
FY12 was not an encouraging start to the year, as most of the operating
surplus during the Q got used up in retail mall/office construction. Going
ahead, for gearing to reduce materially, large-ticket asset monetizations
will need to go through. While news flow of late points to improved
visibility on this account (Rs15-20B), markets may remain skeptical until
these developments finally materialize.
 Key highlights of the analyst call: 1) 1Q FY12 saw DLF generating
positive operating cash flow (after interest/ tax) but this was used up in
rather heavy rental capex (Rs3.3B) implying no surplus. 2) Management
is hopeful about seeing some traction on monetization of assets over the
next 2-3 quarters. Various news reports (e.g. Economic Times) have
indicated assets worth Rs15-20B (Noida/Pune IT Parks, insurance
business and land in Gurgaon) for which the company is in talks with
prospective buyers. 3) As of now the company will look to continue with
its strategy to do largely plotted sales to mitigate construction cost risks
and accelerate cash flows and do selective build out in rental business. It
will not be looking to sacrifice margins in the current environment.
 1Q FY12 results recap: Reported profit of Rs3.6B came in lower than
expectations, primarily on account of lower other income and higherthan-
expected non-core losses. On a core RE EBITDA basis, results were
in-line, thanks to a healthy 47% reported EBITDA margin. This was on
account of a higher mix of plotted to mid-income project mix.
 Estimate changes: We reduce our FY12/13 earnings assumptions by
~17% primarily to factor in higher interest cost and lower other income.
Our pre-sales assumption of Rs61B implies a 8% decrease from last
year’s level and is lower than the guidance level (Rs65-70B).
Correspondingly our normalized cash earnings based Mar-12 price target
of the company is revised down to Rs255.

Oberoi Realty - 1Q below expectations on low revenue recognition ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Oberoi Realty Overweight
OEBO.BO, OBER IN
1Q below expectations on low revenue recognition


estimates on account of a large project (Esquire, Goregaon) not reaching
revenue recognition threshold. Reported earnings of Rs1.06B were aided by
sale of a land parcel (profit of Rs200M) during the quarter. On operating
basis, new bookings were lower Q/Q due to delay in new launches. Going
ahead, progress on new launches (esp. Worli) and deployment of surplus cash
(Rs15.6B) remain the key catalyst for the stock. Management indicated that
they have not yet seen any “accretive” transactions in the market. However,
given the tight funding and weak demand environment, company is optimistic
that there would be land buying opportunity sooner than later.
 Financial Highlights- 1] Development revenues of Rs1B were down 20%
Y/Y/50% Q/Q and sharply below estimates; 2] EBITDA margins stood at
56% in 1Q (vs. 54% in 4Q); 3] Other income at Rs542M (vs. Rs286M in
4Q) was aided by profit of Rs200M on sale of a land parcel in Goa; 4]
Rental income (at Rs317M) was large stable Q/Q.
 Operational Highlights- 1] New bookings at Rs2.6B (down ~25% Q/Q)
with no new launch during the Q; 2] Occupancy for rental assets in
Goregaon project (mall at 94%; Commerz I at 76%) remains large stable
Q/Q. Company guided to occupancy improving to ~95% levels in
Commerz-I by Sep-Q (on the back of a recent LoI); 3] Westin hotel
occupancy (~67%) and ARRs (Rs7.1K) were lower Q/Q given seasonally
weak quarter; 4] Handovers have begun in Splendor project starting July; 5]
O/s sales order book of Rs12.8B yet to be recognized as revenues.
 Analyst Call Highlights – 1] Management remains optimistic on office
space take up (~2msf under construction), however completed office space
at similar rentals in Central Mumbai could pose an oversupply risk, in our
view; 2] Proposed FSI regulation changes in Mumbai are likely to be
beneficial for the company as it does away with the discretionary powers
(ensuring a level playing field) & should smoothen approval process; 3]
Worli project expected to be launched in next 2Qs with contractor now in
place (Samsung) and negotiations underway for international operator.
Mulund launch however still awaits MOEF approval.
PT and Estimate changes– Our FY12/13 estimates are revised down by
11%/19% as we defer sales of office space in Andheri project (Prisma).
Correspondingly our Mar-12 PT (based on 2xFY13 P/B) is revised to Rs270

NTPC - Key takeaways from annual analyst meet ::JPMorgan

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


NTPC Neutral
NTPC.BO, NTPC IN
Key takeaways from annual analyst meet


Timely award of bulk tenders key to avoid slippage in 12th Plan target.
NTPC targets to reach 66.5GW capacity by end-FY17 from 34.8GW
currently (includes 3.4GW JV capacity). The company aims to add ~4.3GW
in balance FY12 and an additional ~9.8GW is under construction.
According to management 660MW/800MW BTG and BOP bulk tenders for
~13.1GW capacity are expected to be concluded before end FY12 (by
~Nov-11). Further delays may result in spillover of target beyond FY17, in
our view.
 Management shares coal requirement and sourcing plan in FY12 and
FY17 (see detailed break-ups inside the report). To achieve 92%
availability of coal based capacity in FY12, management forecasts 14MMT
of imports (equivalent to 23MMT domestic coal or ~14% of total coal
requirement) besides linkages from CIL and SCCL. The situation appears
more challenging in FY17 as 41% of incremental coal requirement
(~47MMT) is slated to be met through captive coal. Management has
factored 12MMT of throughput from 3 mines de-allocated by Ministry of
Coal in their calculation; and is confident of retaining them.
 Back-down led by weak SEB demand pulling down PLFs but
management confident of keeping bottom-line intact. Gas based capacity
(~4GW) had to be backed down and operated at 62% PLF though
availability was 90%. Similar phenomenon was witnessed for coal based
capacity, but to a lesser extent. NTPC being a key govt. owned PSU, and
CIL's largest customer, is relatively better placed in comparison to IPPs for
securing domestic coal. In any case, tie of entire medium term capacity in
assured return RoE model affords safety to bottom-line projections provided
execution remains on track.
 NTPC has marginally underperformed Sensex YTD and by 12% over
last 12months. We maintain our Neutral view and Mar-12 DCF PT of
Rs200. We continue to prefer PGCIL (OW) over NTPC in among regulated
return defensives, given the former’s relatively superior execution track
record and absence of fuel risk. Key upside risk to estimates: RoE gross-up
at PBT level is carried out at peak-tax rate and P&L tax is booked at MAT.
Key downside risk- delay in bulk tender awards, slippage in FY12 target.

Buy PTC India; Target : Rs 120 ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


R o b u s t   m a r g i n s   …
Robust trading margins (4.9 paisa / unit), albeit  lower than expected
volume (6726 MUs v/s expectation of 6966 MUs), robust other income
(26% growth YoY, annualised yield on 9.7% on standalone cash), higher
extra-ordinary expense (| 3 crore) were the key highlights of Q1FY12
result. Valuations are 1.2x at FY11 book value provide comfort. Reiterate
Buy with target price of |118 and rate it as our top pick in the power
sector. While the street is concerned is about long term PPA where delay
in capacity addition can impact volume (seems reasonable at this time),
timely execution of these projects could re rate the stock. While volatile
capital markets have dried up appetite of Power IPOs, monetisation of its
investments (Ind Bharat Power, Teesta Urja) is the key concern for the
stock.
Volumes rise 17% YoY, FY12 & FY13 to see traction in long term trading segment
Calculated trading margins for PTC in Q1 FY12 stood at 8.5 paisa/unit, but
adjusted for the rebates (| 23 crore),  the core trading margins came in at
5.2 paisa/ unit. During the quarter, the company has sold 6726 MUs (+17
% YoY, +30% QoQ). Of these, Long term PPA units were 4200 MUs while
short term PPA was 2526 MUs. The other expenditure included | 1.3
crore payment to Mckinsey and | 1.7 crore for winding up PTC Ashmore
private equity fund.  Average realisation for Q1 FY12 stood at | 3.7 /unit
vs. | 4.8/unit in Q1FY11.
Long term to show meaning full improvement in FY13
There will be marked change in the mix of volumes traded as significant
quantum of long term PPA will get traded as the tied power projects gets
commissioned in FY12 and FY13. The management expects ~1300 MW
of  long  term  PPA’s  to  get  commissioned  and  added  to  volumes  in  FY12
We estimate volumes to grow at CAGR of 50% over FY11-FY13E.
V a l u a t i o n
Valuations at 1.2x P/BV is attractive and have priced in almost all the
concerns realting to power sector. Though the stock might langiush till
the time more clarity merges on commnecement of long term PPA’s, SEB
finances and monetisation of its strategic investments but at the same
time offers attractive opportunity to enter. We therefore value the stock
on a SOTP basis and put target price of |120 per share.

Strong Buy Aurobindo Pharma; Target : Rs 233 ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


F C C B s   g o n e ,   a l l   e y e s   o n   m a r g i n s …
Aurobindo Pharma Q1FY12 results were a mixed bag. The net sales
increased by 17% YoY to | 1076.9 crore in line with our expectation of |
1090 crore. The growth in sales was driven by healthy growth in US
formulations, ARV formulations & SSP APIs businesses. Due to lower
licensing income and higher growth in low margins businesses like ARVs
& SSPs, the EBITDA margins declined by 340 bps to 15.2% YoY. The
company repaid FCCBs and booked entire YTM of | 319.8 crore in P & L
during the quarter. Tax credit of | 87 crore restricted net loss to | 123
crore during the quarter. Excluding EO, the adjusted net profit stood at |
110.3 crore.  
ƒ US business continued to post healthy growth
Sales from US market increased by 26.7% YoY to | 274 crore
despite revenue loss of around | 40 crore from Unit VI on account of
import alert. The company has launched 3 products during the
quarter. It received approval for 6 products. So far, it filed 215
ANDAs with USFDA and received approvals for 138 products
(including 29 tentative approvals)
ƒ Improving capacity utilisation of Unit VII will drive sales growth
In the last fiscal, the company has commissioned Unit VII SEZ
formulation facility. The current capacity utilisation of this facility is
less than 30%. In Q1FY11, the revenues from this facility were
around US$ 30 million. Aurobindo expects sales from this facility to
be around US$ 150-175 million for FY13.    
V a l u a t i o n
We have reduced our FY13E EPS targets by 9% due to some visible
pressure on margins mainly to address the corrective measures at all of
the facilities. We have also cut our price target accordingly. Even then it
remains a strong buy candidate as we believe the correction in the stock
is overdone and it is one of the cheapest available pharma stocks with
good earning history and proven capability and capacity. We value stock
at | 233 based on 9x FY13E EPS of  | 25.9. Existing share holders who
bought the stock at | 193 at the time of Q4FY11 update can continue to
hold the same.

Banks- Still amid choppy waters; stocks not yet ready for upturn ::Goldman Sachs

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Still amid choppy waters; stocks not yet ready for upturn
Stocks trading in a narrow range; no significant positive catalysts
Since May 2011, Indian financials’ stocks have traded sideways due to multiple
headwinds: (1) Sticky inflation, (2) policy tightening, (3) Potential growth
deceleration, (4) increasing risk to asset quality, (5) weaker earnings outlook on
margin pressure. While inflation and interest rates are close to their peaks, we
believe earnings would remain under pressure on lower margin, higher NPLs.
Stocks peak/bottom before inflation does, but are not overvalued
Our analysis of historical trends indicate that the financials sector displays a
high correlation with inflation, interest rates, GDP, IIP and suggest that banking
stocks tend to peak/bottom 4-6 months ahead of inflation levels peaking/
bottoming. Our GS Global ECS Research team forecasts inflation to peak in
Aug-Sep 2011 and believes there is a high probability that rates have peaked.
While investor holdings in the banking sector remain high, current valuations
are not at their peak vs. the previous cycle, and hence we do not expect a
sharp adjustment. We also believe outperformance is unlikely till we see
earnings correction, thereby leading to stocks trading in a narrow range.
Earnings performance to remain under pressure next few quarters
Lower loan growth at 18%-20% vs. over 21% last year, margin decline of
50-100 bps vs. peak in Dec 2010, MTM hit on investment portfolio, and lack
of treasury gains will lead to muted profit growth in FY12, in our view.
NPLs too will see a cyclical uptick, which will likely have a P&L impact. On
the positive front, we find banks have hiked lending rates (PLR at 14.25%
vs. 14%) more than deposit rates (9.25% vs. 10.5%) this cycle and margin
pressure will likely be less vs. the past. If RBI hikes rates any further,
margin compression could be more than expected, in our view.
Earnings headwinds likely to persist; we remain selective
While the sector is not overvalued, select sector defensives—HDFC Bank/HDFC/
Kotak—are trading at expensive valuations; rated Sell. We suggest being
selective and prefer private banks to PSU banks as we believe they are able to
manage their spreads better than PSUs through the rate cycle (Sell BOI). Our top
picks: IndusInd (Buy, on CL) and Yes Bank (Buy) given their strong earnings
growth as we believe margin pressure will be offset by higher CASA ratio; ICICI
Bank (Buy) – better growth prospects and the international book repricing to help
sustain its margins. We revise our 12-m TPs for stocks yet to report 1QFY12
results by 2%-5% as we roll forward our target BVPS to June-2012.

Buy Kamat Hotels; Target :Rs 95 ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


B e t t i n g   o n   A s s e t   V a l u e …
Kamat Hotels reported net sales of | 30.3 crore (up 6.3% YoY, down 7.8%
QoQ) for the quarter ended June’11. This remained marginally below our
expectations (I-direct estimate: | 31.6 crore). The growth in revenue came
in from Nashik (growth of 13% YoY) and Pune region (growth of 20%
YoY) while growth in Mumbai (growth of 5% YoY), which is a key driving
factor remained subdued. Operating costs for the quarter also remained
higher and grew 12% YoY to | 21.3 crore. Among operating costs
components, raw material, employee costs and power and fuel cost
increased 22%, 11% and 15% YoY, respectively. However, with the lower
interest outgo, the company reported ~105% YoY jump in its net profits
to | 0.35 crore (I-direct estimate: profit of | 0.2 crore).

ƒ Demand continues to remain sluggish
Kamat Hotels’ Q1FY12 topline grew by only 6% YoY to | 30.3 crore
on account of subdued demand for hotel rooms especially in
Mumbai, contributing over 85% of topline. Occupancy levels for
Orchid Mumbai increased marginally by 100bps YoY to 71%, while
VITS Mumbai reported 400bps YoY drop in average occupancy
levels to 79% on account of subdued demand.

ƒ Higher employee and raw material cost takes toll on margins
Operating costs for Q1FY12 grew  by 12% YoY to | 21.3 crore.
Among operating cost components, the raw material and power and
fuel cost increased by 22% and 15% YoY, respectively. As a result,
operating margins declined by 366 bps YoY to ~30%.
V a l u a t i o n s
At the CMP of | 80, the stock is trading at 10.9x and 7.4x its FY12E and
FY13E EV/EBITDA, respectively. We believe the Mumbai region is still in
the nascent stage of recovery and is yet to make the transition from
occupancy led cycle to the one supported by rising room rates. We lower
our F12E and FY13E EPS by ~36% and ~19% respectively. We value the
stock at 9.0x FY13E EV/EBITDA and lower our target price to |. 95 with a
Buy rating on the stock.

Hindalco Industries-- All eyes on expansions :: Macquarie Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Hindalco Industries
All eyes on expansions
Event
 Results above estimates: Hindalco reported results for 1Q FY12, which
were marginally above our estimates on lower than expected increase in
costs. Current operations remain stable and all eyes are on expansion
projects both from completion date and cost over-run point of view.
Management has largely maintained its guidance here.  We maintain
Outperform and TP.
Impact
 Strong results – despite lower production: Net sales of Rs60bn is up 16%
YoY driven by strength in aluminium and copper prices. Aluminium division’s
PBIT at Rs6bn, was up 8.5% YoY, with costs eating into higher aluminium
realisation. Copper division reported PBIT of Rs1.5bn, up 17% YoY despite
lower production due to bi-annual shutdown. PAT at Rs6.4bn is up 20% YoY
helped by higher other income.
 Aluminium Division- can face some pressure: With aluminium price
reducing below our assumption of US$2535/t for FY12, we expect some
pressure on earnings. For every 10% decrease, the earnings reduce by 14%.
We do expect some volume growth from completion of Hirakud smelter
expansion, and possibly Mahan smelter coming on line in 2
nd
half.
 Copper division – expect better profitability: Tc/Rc’s for 2011 have been
settled at 20% higher rates as compared to 2010, led by surplus in
concentrate market. Falling copper prices reduce working capital requirement
but benefit is negated due to lower earnings on free metal. Volume should
increase as smelters are back in operation following bi-annual maintenance
shutdown.
 Expansions largely on track: Hindalco has maintained that 0.4mt Mahan
aluminium smelter will be commissioned starting this year, while its 1.5mt
Utkal alumina refinery is now more specifically mentioned starting in 2
nd
half
2012 against earlier guidance of just 2012. While management does mention
inflationary pressure on project costs, but no increase has been done to
estimates as yet.
Earnings and target price revision
 No change.
Price catalyst
 12-month price target: Rs270.00 based on a PER methodology.
 Catalyst: Further price increases by Novelis and strength in Aluminium prices
Action and recommendation
 Maintain Outperform: Hindalco is the best aluminium play in the region in
our view. Stable earnings from Novelis which is 60% of earnings; provide a
great buffer while its low cost Indian operations provide the leverage to rising
aluminium prices. Maintain Outperform.

Implications of Chinese Moves \:: Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Implications of
Chinese Moves
What’s New: China seems to be letting its currency
appreciate at a faster pace.  Simultaneously, labor costs
appear to be rising in China.  In summary, China seems
focused on stimulating domestic consumption demand.
The risk is that these trends accentuate with implications
for Corporate India.
Implications:  We are hearing from a select group of
Indian companies that Chinese goods are getting more
expensive.  China is India’s single-largest trading
partner with just under one-tenth of India’s total trade.
Statistically speaking, UAE is a tad bigger, but one can
argue that UAE is a trading hub for Indian output and
input rather than a direct consumer/supplier.  
Capital goods: The ongoing developments appear to
be very positive for industrials. Nearly two-thirds of all
imports from China are capex related.  Indian industrial
suppliers including Larsen & Toubro (LART.BO,
Rs1,640.75) will likely benefit from more-expensive
Chinese imports in the medium term.
Power companies: Several power companies have
placed orders with Chinese firms and may face higher
equipment costs. These include LANCO Infra (LAIN.BO,
Rs17.60, Reliance Infra (RELI.BO, Rs773.40) and Adani
Enterprises (ADEL.BO, Rs572.15).
Pharmaceutical companies: India imports a fair bit of
its API intermediates from China.  We estimate rising
Chinese costs will hurt Indian players with an
approximate 1% margin impact.  However,
simultaneously, Chinese competition in the international
market will become less intense, possibly pushed back
by three to four ears. This would help Indian companies
further entrench themselves as global generic players.
Indian consumers: Indian consumers have benefited
from cheap Chinese goods in recent years, especially in


segments such as clothes, toys, sports goods, ceramics,
leather, silk and even umbrellas.  These goods will become
expensive, at the margin. On the other hand, Indian SMEs
stand to gain competitiveness over time.  
Indirect implications: Indian companies compete with
Chinese companies in sectors such as textiles, and we expect
them gain competitiveness.  Consumer goods, which may be
coming to India via other countries but are manufactured in
China, may also lose competitiveness to Indian companies.  
Commodity complex: The impact on commodities is quite
complicated and beyond the scope of this short report, but in
our view is something to keep in mind.  
Conclusions: It is still early days, but we would keep a watch
on this space for medium-term implications on business
models.

UBS - Tata Steel Ltd.- 1QFY12 results ahead of estimates „

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Tata Steel Ltd.
1QFY12 results ahead of estimates
 
„ Event:  1Q Beat due to higher EBITDA; PAT driven by one-off gains
Consolidated pre-ex PAT of Rs14.7bn (-12%QoQ, -21%YoY) was higher than
UBS-e of Rs11.2bn due to higher EBITDA (Rs42.6bn,+18% QoQ, +0%YoY) in
both India/Corus. Net Sales of Rs328.4bn was in line. Reported PAT of 53.5bn
included Rs39bn in one-off gains. Corus’ EBITDA/t at US$78/t was higher (UBSe, US$31/t) due to higher ASP of US$1,313/t (+10%QoQ) while EBITDA/t in
India at US$422/t was higher (UBS-e, US$387/t) due to lower raw material costs
„ Impact: 2QFY12E to be impacted by higher coking coal /lower steel prices
We believe though 1Q results were ahead of estimates, 2Q is likely to be subdued
due to full impact of higher coking coal/lower steel prices. Tata Steel today 1)
marginally increased capex guidance for FY12/13 from US$2bn each to US$2.2-
2.5bn each due to faster progress on Odisha project.  2) Commissioning of 2.9mt
expansion in Jamshedpur is delayed to 4QFY12 from 3QFY12.  There is some
downside to our volume est of 7.2/9.5mt for FY12/13 (co. indicated 6.6/9.2mt). 3)
However, coking coal shipment from Mozambique is on track by FY12end
„ Action: Stock at attractive levels post correction due to Eurozone concerns
We believe earnings growth for Tata Steel will be supported by: 1) 43% capacity
expansion in highly profitable Indian operations by FY12end, 2) partial backward
integration in Corus by FY 13 (from 0% in coal /iron ore to 10%/18%)
„ Valuation: Maintain Buy and PT of Rs860
We continue to value Tata Steel on SOTP basis with Indian business at 7.4x,
Europe at 6x and others at 6.5x EV/EBITDA on normalized EBITDA (FY12-13E).


Q Tata Steel Ltd.
Established in 1907, Tata Steel, the Tata Group's flagship company, is the
world's sixth largest steel company with presence in 50 countries and crude steel
production capacity of 30mtpa, following the acquisition of Corus Group in
2007. It plans to increase production capacity in its Jamshedpur plant, one of the
world's most modern steel making and finishing facilities, from 6.8mtpa to
10mtpa by 2010. Tata Steel has captive iron ore and coal mines. It has plans for
greenfield expansion in Jharkhand, Orissa and Chhattisgarh.
Q Statement of Risk
Our earnings estimates and valuation are subject to fluctuations, based on global
and domestic steel prices and the prices of key raw materials such as coking coal
which are difficult to predict. Tata Steel’s backward integration for key raw
materials such as iron ore and downstream expansion into value added products
would only partly mitigate the impact of these variables.

Hold Orbit Corporation; Target : 41 ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


V o l u m e   o f f t a k e   a t   n a d i r   …
Orbit Corporation (Orbit)  had a  disappointing  operating performance in
Q1FY12 due to slower execution of projects and persistent poor volume
off takes. The topline declined by ~29% YoY to | 85 crore marred by
slow execution. The margin at 38.4% was lower on account of cost
overrun to the tune of ~| 8 crore in Orbit WTC. While, we anticipate that
cash flow from Orbit WTC & sale of Ocean Parque would be key triggers
for the stock price performance, we  expect weak pre-sales volume and
pledging of shares (~55%) would remain overhang for the stock.
ƒ Pre-sales weakness persists
The pre-sales volume has come down further to 9,985 sq ft in Q1 FY12
v/s 11,249 sq ft in Q4 FY11 on account of no new launches during the
quarter and receding volume offtake in existing projects. The pre-sales
volume (lowest in last 10 quarter) clearly reflects weak buyer sentiments
and price moderation is inevitable for pickup in the volume
ƒ Launch pipeline key for cash flows going ahead
The company indicated that it is looking to launch 3 projects (Lalbaugh,
Santacruz and Napeansea Road) in FY12. We believe successful launch
of the same would be key for the cash flows which have not seen any
improvement from the last couple of quarters
ƒ Ocean Parque sales deal in discussion
Orbit informed that it is in discussion with Mahindra Lifespace for sale
of Ocean Parque project at Napeansea Road. Mahindra Lifespace has
signed the term sheet and Orbit has received advance of | 11 crore. The
deal is expected at ~| 235-250 crore. Ocean Parque sale receipt will be
a boost to crunch cash flow situation of the company
V a l u a t i o n
At the CMP, the stock is trading at 0.4x FY13 P/BV. Though we anticipate
that cash flow from Orbit WTC & sale of Ocean Parque would be key
triggers for the stock price performance, we recommend Hold on the
stock given the weak volume offtake in Mumbai and challenging funding
environment for the industry. Additionally, pledging of shares by
promoters (55%) would remain overhang for the stock.

Money Alerts - upcoming NCDs:: Business Line,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


There is an interesting trend emerging from the recent debenture issuances. The issuing companies are coming out with better rates than the previous ones.
Manappuram NCD
Even as investors are queuing up for long-term debt options, the 400-day secured non-convertible debenture (NCD) from Manappuram General Finance (Manappuram) can be considered. The cumulative option which has a yield-to-maturity of 12 per cent despite carrying some risk, is worth investing in, as the near term business outlook continues to be encouraging for Manappuram.
Manappuram, being concentrated on the gold lending business, is exposed to gold price volatility. Yet, it has good net interest margins. The outlook for gold prices, a key determinant of prospects for gold lending, appears stable after the recent economic events. In any case, a low loan to value on gold loans, also provides some buffer to gold loan companies against a correction in gold prices.
Strong capital adequacy levels of 21.8 per cent also gives some confidence in the investment. The credit rating of CARE AA- is however, one notch lower to that of Shriram City Union Finance which makes it slightly more risky.

THE ISSUE

The 400-day deposit rates of banks offer rates that are at least 1.5 percentage points lower than this debenture, which is to be seen in light of their much safer risk profile. Lakshmi Vilas Bank and City Union Bank offer 10.5 per cent and 10.4 per cent interest rates for a 400-day deposit.
Investors who plan to invest with a two year perspective can, however, give this offer a skip for now. The company's main competitor Muthoot Finance, is also coming up with a two year option in its upcoming issue.

ABOUT THE COMPANY

Manappuram General Finance has a branch network of 2,280 with three fourth of the branches in the South. The gold financing accounts for 99.2 per cent of the loan book (Rs 8915 crore as of June 2011). The interest spread for the year ended March 2011 was very high at 16 per cent. The Net NPA at 0.3 per cent also gives some comfort. The Rs 750 crore issue (with Rs 350 crore oversubscription) opens on August 18 2011 and closes on September 5 2011. However, the issue could be pre-closed if it gets oversubscribed before the closing date.
Shriram City Union Finance
Investors can subscribe to the Shriram City Union Finance's public offer of three-year secured NCD.
Shriram City's three-year NCD option offers an annual interest payout at 11.85 per cent for investments of less than Rs 5 lakh. The rate is 11.6 per cent for other individuals.

ATTRACTIVE RATES

The 11.85 per cent three-year option is attractive vis-à-vis bank deposits. The average bank deposit rate of banks is close to 9 per cent for three-year maturity. While not strictly not comparable, the spread between the NCD issue and bank deposit rates, in excess of 2.8 percentage points, more than compensates for the marginally higher risks.
Apart from investment grade rating, the company's established track record and expectation of interest rates nearing the peak also make the offer attractive. The yields on similar (CARE AA) rated instruments issued by Non-Banking Finance Companies (NBFCs) in the secondary market are close to 10.1 per cent.

ABOUT THE COMPANY

Shriram City Union is a diversified retail financing NBFC which is predominantly engaged in financing small and medium enterprise (SME) loans, loan against gold and auto financing. The company operates through 650 point of presence with high concentration in Andhra Pradesh and Tamil Nadu.
For the quarter ended June 2011, the net profit was Rs 80 crore and the interest spreads were in excess of 11.6 per cent. It has a loan book size Rs 8,005 crore on the book. The net NPA to a low 0.44 per cent. The capital adequacy ratio too was at a comfortable 20.13 per cent.

ISSUE DETAILS

The issue has a minimum investment amount of Rs 10,000. The offer opened on August 11 and closes on August 27; with an option to pre-close the issue. The allotment is on a first-come-first-serve basis. NCDs will be listed on both BSE and NSE

Ruchi Soya Industries Update ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


E n h a n c e d   c a p a c i t y   u t i l i s a t i o n   a i d s   g r o w t h   …
Ruchi Soya Industries Ltd’s (Ruchi Soya) Q1FY12 revenue increased
70.6% YoY to | 5,898.9 crore on the back of enhanced capacity utilization.
The company was able to maintain the EBITDA margin at 2.8% and
reported an EBITDA of | 162.3 crore.  Sale of branded products also
increased by 46.8% from | 832 crore in Q1FY11 to | 1,266 crore in
Q1FY12. Higher depreciation and interest outgo weighed on the
bottomline leading to a subdued 26.2%  growth in PAT to | 66.2 crore.
Q1FY12 was a good quarter for the company on the back of rising global
and domestic commodity prices.
ƒ Segmental Analysis
In Q1FY12, the oils, vanaspati and seed extraction segment posted a
YoY growth of 76.4%, 10.2% and 115.3% to | 4,782 crore, | 253.5
crore and | 696.0 crore, respectively. The oils and vanaspati
segment witnessed an EBIT margin expansion while the seed
extraction segment witnessed compression in EBIT margins. EBIT
margin for the oil business increased from 1.7% in Q1FY11 to 1.9%
in Q1FY12 while the EBIT margin for the vanaspati segment
increased significantly from 1.6% in Q1FY11 to 2.0% in Q1FY12.  On
the other hand, EBIT margin for the seed extraction business
decreased from 3.8% in Q1FY11  to 2.9% in Q1FY12. The EBIT
margin in the food business remained flat at 3.2%.
ƒ Volume growth on the back of enhanced capacity utilization
Ruchi Soya witnessed healthy volume growth in Q1FY12. The
capacity utilization of the crushing activity improved 109% to
4,11,601 MT from 1,97,137 MT in Q1FY11. The export volume of
oilseed extraction improved 236%, from 82,832 MT to 2,78,053 MT.  
V i e w
Higher capacity utilization and increased focus on exports aided strong
growth in FY11 and the same has continued in Q1FY12 as well. With
increased capacities Ruchi Soya is  well poised to capitalize on the
incremental demand with capacities in place.

Buy JBF Industries; Target : rs 154 ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


D u l l   q u a r t e r   a f t e r   a   b um p e r   F Y 1 1…
JBF Industries Ltd’s (JBF) Q1FY12 numbers were ahead of our estimates
on the revenue and EBITDA front; however, on the PAT front they were in
line with our estimates. Consolidated net sales increased 12.5% YoY to
| 1,590.6 crore as against our estimate of | 1,293.4 crore. Domestic and
international volumes were in line  with our estimates (we modelled ~
12% blended volume de-growth); blended realisations increased ~35%
YoY (higher than our estimate). Key raw material prices (PTA, MEG) too
increased ~35% YoY. As a result, JBF was able to maintain its EBITDA
margin at 10.1% in Q1FY12 versus 11.0% in Q1FY11 and 14.4% in
Q4FY11. Due to higher forex and derivative losses of | 45.4 crore (| 13.0
crore in Q1FY11), JBF witnessed a YoY PAT de-growth of 4.8% to | 52.3
crore (I-direct estimate: | 49.4 crore). We have trimmed our FY12E and
FY13E estimates considering factors like plant shutdowns due to raw
material availability issues and slowdown in demand due to softening
cotton prices (which reduces substitution demand). Also due to inventory
pile up we expect some pressure on the operating margin and have
reduced our EBITDA margin expectations from 14.6% to 12.2% and
13.6% to 12.6% for FY12E and FY13E respectively.  
ƒ Capacity expansion on track
JBF’s expansion plans seem to be on track. During Q1FY12, the
domestic chips capacity has increased by 58,000 tonnes per annum
(TPA) to 6,08,800 TPA. Also the domestic POY (polyester oriented
yarn) capacity has also increased from 1,72,000 TPA in FY11 to
2,45,000 TPA.
V a l u a t i o n
FY11 was an exceptionally good year for JBF backed by strong
realisations across all products, more so in the BOPET films segment.
However Q1FY12 does not seem to reflect the same story and hence we
have reduced our EBITDA margin and EPS estimates for FY12E and
FY13E. Bearing  in mind a weak outlook,    lowered estimates,   pressure on
the balance sheet and increasing interest burden due to the capex plans,
we have further downgraded our target price from | 185 to | 154 (based
on an average of 3.0x FY13E EPS and 0.4x FY13E book value). We have a
BUY rating on the stock.

Buy Gujarat State Petronet Ltd (GSPL) Target : Rs116 ::ICICI Securities,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


V o l u m e s   m a r g i n a l l y   a b o v e   e s t i m a t e s …
GSPL has declared its Q1FY12 results. GSPL reported revenues of | 287.6
crore (up 13% YoY), EBITDA of | 265.2 crore (up 10.1% YoY) and PAT of
| 137.4 crore (up 30.7% YoY. The revenues are above our estimates on
account of transmission tariffs which grew by 6.5% YoY to | 0.81 per scm
& volumes which grew marginally by 1.2% YoY to 3344.8 mmscm (36.8
mmscmd); however, profitability was below our estimates on account of
increase in depreciation & interest costs on a QoQ basis. The gas
transmission volume grew marginally by 1.4% YoY & 3.4% QoQ to 36.8
mmscmd. We estimate GSPL’s volumes of 37.8 mmscmd and 43.8
mmscmd in FY12E and FY13E, respectively. We expect the final approval
for authorisation of its pipelines  in Q3FY12 from PNGRB when its
transmission tariffs would be finalised. We estimate gas transmission
tariffs of | 0.75 per scm for GSPL from Q3FY12 onwards. GSPL led
consortium has been awarded letter of authorisation for MallavaramBhilwara, Mehsana-Bhatinda, Bhatinda-Jammu- Srinagar pipelines which
would provide upside to the stock, going forward. GSPC Gas (GSPL holds
~40% stake in the company) also intends to come out with an IPO in
H2FY12E/ H1FY13E. GSPC reported PAT of | 148 crore in FY11. We
believe that IPO would unlock value for GSPL. We recommend BUY on
GSPL, with a target price of | 116.
ƒ Highlights of the quarter
GSPL reported marginally higher gas transmission volumes on a
YoY as well as QoQ basis at 36.8 mmscmd in Q1FY11 due to higher
R-LNG volumes. The gas transmission tariffs grew 6.5% YoY & 2.9%
QoQ at | 0.81 per scm in Q1FY12. GSPL (52% share) led consortium
(OMC’s -IOC, BPCL, HPCL) would set up Mallavaram-Bhilwara,
Mehsana-Bhatinda, Bhatinda-Jammu- Srinagar pipelines with an
investment of | 12,500 crore  within a period of 36 months.
V a l u a t i o n
We  continue  to  remain  positive  on  GSPL on account of steady growth in
volumes and profitability. New pipeline bids would also add value to the
stock. Currently, we have not modelled in these pipelines in our
estimates. We have valued GSPL based on DCF (WACC-11.8%, terminal
growth-2%) to arrive at a price target of | 116.